RDY – dr. reddy's laboratories ltd (US:NASDAQ)
Stock Stats
News
Zydus to launch generic semaglutide injections in India after patent expiry in March [Yahoo! Finance]
Dr. Reddy’s Announces USFDA Acceptance to Review Its Biologics License Application (BLA) for Proposed Interchangeable Biosimilar, Abatacept
Dr Reddy's aims to launch generic obesity drug at 60% discount [Yahoo! Finance]
Dr. Reddy's Laboratories (NYSE:RDY) was downgraded by analysts at Weiss Ratings from a "buy (b-)" rating to a "hold (c+)" rating.
Dr. Reddy's Laboratories (NYSE:RDY) was upgraded by analysts at Weiss Ratings from a "hold (c+)" rating to a "buy (b-)" rating.
Form 6-K DR REDDYS LABORATORIES For: Feb 24
Form 6-K DR REDDYS LABORATORIES For: Feb 18
Form 6-K DR REDDYS LABORATORIES For: Feb 17
Form 6-K DR REDDYS LABORATORIES For: Jan 14
Form 6-K DR REDDYS LABORATORIES For: Feb 12
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.